We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
-14.18%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$174M
AUM Growth
-$181M
Cap. Flow
-$142M
Cap. Flow %
-81.5%
Top 10 Hldgs %
28.03%
Holding
1,070
New
55
Increased
89
Reduced
355
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 15.03%
2 Healthcare 12.1%
3 Energy 10.33%
4 Industrials 6.98%
5 Consumer Staples 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GHG
251
GreenTree Hospitality
GHG
$113M
$112K 0.06%
26,852
SSB icon
252
SouthState Bank Corp
SSB
$10.3B
$111K 0.06%
1,444
+42
+3% +$3.27K
NEM icon
253
Newmont
NEM
$98.2B
$111K 0.06%
1,857
-6,324
-77% -$447K
HTBK
254
DELISTED
Heritage Commerce
HTBK
$110K 0.06%
10,338
FVRR icon
255
Fiverr
FVRR
$376M
$108K 0.06%
3,143
HRI icon
256
Herc Holdings
HRI
$5.43B
$108K 0.06%
1,197
-810
-40% -$97.3K
OBK icon
257
Origin Bancorp
OBK
$1.66B
$108K 0.06%
2,776
+77
+3% +$3.03K
IQV icon
258
IQVIA
IQV
$34.7B
$106K 0.06%
490
PTH icon
259
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$166M
$106K 0.06%
2,775
NBIX icon
260
Neurocrine Biosciences
NBIX
$17.7B
$106K 0.06%
1,084
+1,081
+36,033% +$99.8K
NIO icon
261
NIO
NIO
$11.3B
$103K 0.06%
4,724
-5,957
-56% -$109K
RJF icon
262
Raymond James Financial
RJF
$32.5B
$101K 0.06%
1,130
-1,517
-57% -$149K
MSCI icon
263
MSCI
MSCI
$40B
$99.7K 0.06%
242
-413
-63% -$180K
NTES icon
264
NetEase
NTES
$76.5B
$99.6K 0.06%
1,067
-3,760
-78% -$358K
LMT icon
265
Lockheed Martin
LMT
$134B
$98.9K 0.06%
230
+1
+0.4% +$439
FCX icon
266
Freeport-McMoran
FCX
$90B
$97.6K 0.06%
3,337
-38,521
-92% -$1.54M
MBIN icon
267
Merchants Bancorp
MBIN
$2.19B
$96.2K 0.06%
4,246
+90
+2% +$2.19K
CMA
268
DELISTED
Comerica
CMA
$96K 0.06%
1,309
-205
-14% -$16.6K
PHAT icon
269
Phathom Pharmaceuticals
PHAT
$912M
$94K 0.05%
11,141
+5,267
+90% +$54.2K
KRTX
270
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$93.6K 0.05%
740
KNSA icon
271
Kiniksa Pharmaceuticals
KNSA
$4.83B
$92K 0.05%
9,496
CASH icon
272
Pathward Financial
CASH
$1.81B
$88.1K 0.05%
2,279
-267
-10% -$11.4K
AXSM icon
273
Axsome Therapeutics
AXSM
$12.4B
$87.3K 0.05%
2,279
+2,249
+7,497% +$71.1K
AUPH icon
274
Aurinia Pharmaceuticals
AUPH
$1.97B
$87.2K 0.05%
8,683
CHTR icon
275
Charter Communications
CHTR
$14.7B
$86.7K 0.05%
185
-5
-3% -$2.44K

Similar funds

Exane Derivatives's Q2 2022 Portfolio in Review

As of Q2 2022, Exane Derivatives held 1,070 positions worth $174M, down 51% from $355M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Exane Derivatives withdrew a net $142M in Q2 2022, closing 309 positions and reducing 355 holdings. Its most notable exit was Amazon, an estimated $5.98M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Exane Derivatives opened a new position in iShares Core US Aggregate Bond ETF worth $4.5M.

  • Exane Derivatives's largest Q2 2022 buy was iShares Core US Aggregate Bond ETF: 44,298 shares worth $4.5M.
  • Exane Derivatives added most to Dow Inc in Q2 2022, an estimated $1.28M increase.
  • Exane Derivatives's biggest Q2 2022 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $4.74M.
  • Exane Derivatives fully exited Amazon in Q2 2022, selling an estimated $5.98M.
  • Exane Derivatives's ten largest holdings make up 28% of its $174M portfolio in Q2 2022.
  • Exane Derivatives opened 55 new positions and closed 309 in Q2 2022.
  • Exane Derivatives's portfolio value fell 51% quarter-over-quarter to $174M.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.